Physician

James Onorato, M.D., PH.D.

According to 2025 Medicare claims, James Onorato, M.D., PH.D. (NPI: 1679504559) practices nephrology in the Lewiston, ID-WA market, with the plurality of this provider's patient population coming from Asotin, WA. This provider's primary affiliated billing organization is TRI-STATE MEMORIAL HOSPITAL (NPI: 1598814352; TIN: 910545036) and primary practice location at 99403-0189. Onorato is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), PSW ACO (ACO ID: A5323), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Onorato's data goes back to 2015 and runs through 2024. For example, in 2023, this provider had 14 traditional Medicare patients, billed 40 HCPCS/CPT codes, and received $3,032 in Medicare payments. 2024 Part D data shows 2,779 prescription claims across 346 beneficiaries totaling $130,227 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2024 DME data shows 126 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $65,182 to $3,032. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $29,372 to $130,227. For DME billing, reported payments fell sharply in recent years, from $5,218 to $1,631.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	275	842	$65,182
2016	331	784	$59,436
2017	287	771	$55,447
2018	233	685	$48,764
2019	88	267	$18,915
2020	40	129	$9,964
2021	44	154	$12,668
2022	16	42	$3,306
2023	14	40	$3,032
2024	N/R	N/R	N/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	129	366	$29,372
2016	128	364	$22,921
2017	144	435	$29,918
2018	153	490	$45,581
2019	303	1,351	$73,723
2020	279	2,284	$131,582
2021	302	2,572	$199,700
2022	292	2,501	$170,952
2023	309	2,697	$184,228
2024	346	2,779	$130,227

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	32	$1,878
2017	N/R	52	$1,849
2018	N/R	76	$3,008
2019	N/R	54	$699
2020	N/R	196	$4,062
2021	N/R	184	$3,355
2022	N/R	175	$4,003
2023	N/R	161	$2,751
2024	N/R	126	$1,963

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	21	1,110	$18,831
Jardiance	Empagliflozin	34	966	$17,713
Eliquis	Apixaban	14	420	$8,109
Entresto	Sacubitril/Valsartan	11	330	$7,359
Potassium Citrate Er	Potassium Citrate	81	2,905	$5,671

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	33	$477
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	26	$452
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	11	$447
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	27	$393
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	12	$187

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for James Onorato, M.D., PH.D.?

Tedicare shows public-source Medicare data for James Onorato, M.D., PH.D. (NPI 1679504559), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Onorato, M.D., PH.D. have ACO affiliation data?

James Onorato, M.D., PH.D. is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), PSW ACO (MSSP, ACO ID A5323), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to James Onorato, M.D., PH.D.?

James Onorato, M.D., PH.D. is linked to TRI-STATE MEMORIAL HOSPITAL (billing NPI 1598814352) in the available physician profile data.

Does James Onorato, M.D., PH.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.